GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
12.7475 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, ESR1, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, KCNH2, KDR, MAOB, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, XDH |
12.4388 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
10.7447 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FUT7, HMGCR, MIF, PDE5A, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
9.86443 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, MIF, PTGS1, PTGS2 |
9.32619 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HMGCR, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
9.13216 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, MIF, PTGS1, PTGS2 |
9.13216 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MAOB, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SLC6A4, SRC, TYR |
9.13216 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F10, F3, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
9.02464 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F10, F3, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
9.00706 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.88923 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, NQO2, PTGS1, RORC |
8.81549 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
8.48173 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, MAOB, NQO2, PTGS1, PTGS2, TYR, XDH |
8.17096 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MAOB, MMP2, PIK3CA, PPARA, PTGS2, RORC, SLC6A4, SRC, TYR |
7.83525 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
7.83525 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC1A1, SLC6A4, SRC, TERT, XDH |
7.79747 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, F10, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
7.79747 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PDE5A, PIM1, PTGS1, PTGS2, SLC6A4, SRC, TERT, XDH |
7.73826 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, F10, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
7.66381 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.61531 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, MIF, PTGS1, PTGS2 |
7.57894 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS1, PTGS2 |
7.45208 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
7.30467 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
7.07961 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
7.05082 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AXL, CYP1B1, F10, F3, FLT3, GRM1, HMGCR, KDR, MET, MIF, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.88958 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 |
6.88958 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.60089 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.60089 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, MAOB, PTGS2, RORC, SLC6A4, SRC, TYR |
6.57802 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
6.56275 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
6.49538 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRB, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TYR |
6.45969 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AXL, CSNK2A1, CYP1B1, F10, F3, FLT3, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
6.45969 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
6.37339 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
6.30008 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CB, SRC, XDH |
6.20308 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, MAOB, MMP2, PPARA, PTGS2, SLC6A4, SRC |
6.16419 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
6.14374 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR |
6.11247 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
6.08901 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SLC6A4, SRC, TERT |
5.99684 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F10, F3, GRIK5, GRM5, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
5.95981 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2, SLC6A4 |
5.95981 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2, SLC6A4 |
5.95981 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
5.90767 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.87804 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FLT3, MAOB, PTGS2, RORC, SLC6A4, SRC, TYR |
5.85405 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, PTGS2, SRC, TERT |
5.82379 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.79854 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F10, F3, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.70368 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.70368 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS1, PTGS2 |
5.66871 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
5.65374 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, MAOB, PPARA, PTGS2, SLC6A4, SRC |
5.63027 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, CDC25B, DRD1, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.47538 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, CDC25B, DRD1, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.47538 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4 |
5.47054 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, CDC25B, DRD1, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.47054 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, CDC25B, CSNK2A1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
5.45432 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, AURKB, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
5.45231 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AXL, CSNK2A1, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
5.442 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, CDC25B, DRD1, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.42614 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP2, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
5.2755 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, AKR1C3, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PTGS2, RORC, SRC |
5.19374 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AKR1C3, AURKB, CDC25B, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
5.15737 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.12342 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
5.01906 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
4.97762 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.92566 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, AXL, CYP1B1, DRD1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SLC6A4, SRC |
4.91952 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MIF, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT |
4.90157 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, DRD1, HCAR2, HMGCR, KDR, MIF, PIK3CB, PTGS2, SRC |
4.88741 |
[BP] GO:0006693 |
None
|
AKR1C3, CES2, MIF, PTGS1, PTGS2 |
4.88741 |
[BP] GO:0006692 |
None
|
AKR1C3, CES2, MIF, PTGS1, PTGS2 |
4.88741 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.88019 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, PIK3CA, PTGS2, RORC, SLC6A4, SRC |
4.88019 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
4.88019 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, CDC25B, ESRRB, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.82274 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.81299 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, AXL, CA12, CA2, CA7, DRD1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, KCNH2, MET, PIK3CA, PIK3CB, SRC, TERT |
4.79276 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, CDC25B, DRD1, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
4.72893 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, HMGCR, MAOB, TYR |
4.66067 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.60814 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, HMGCR, IGF1R, MIF, PDE5A, PIK3CB, PTPN1, SRC |
4.5954 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.46254 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, F10, F3, MET, PIK3CA, PIK3CB, SRC, XDH |
4.43559 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F10, F3, MET, PIK3CA, PIK3CB, SRC |
4.43559 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, MAOB |
4.4186 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CA7, CYP19A1, DRD1, GRIK5, GRM5, HCAR2, HMGCR, KCNH2, MAOB, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
4.41356 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.40126 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
4.39944 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.3555 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, FABP3, HMGCR, KCNH2, KDR, MAOB, PTGS2, SLC6A2, SLC6A4, SRC |
4.3555 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CA2, CA9, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B2, KDR, MAOB, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SLC6A4, SRC, TERT, TYR |
4.34928 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
4.28593 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.26216 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.14802 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, CDC25B, DRD1, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.1004 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.06691 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.05075 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.03591 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
4.03427 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
4.012 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, GRM1, GRM3, GRM5, GRM8 |
3.99013 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2, TERT |
3.99013 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, DRD1, HMGCR, KDR, MAOB, SLC6A4, SRC |
3.97525 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
3.94871 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.90098 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, GRIK5, MAOB, PTGS2, SLC1A1, SLC6A2, SLC6A4 |
3.84996 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.828 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, FLT3, GRM1, HMGCR, KDR, MIF, PDE5A, PIK3CB, PTPN1, SRC, XDH |
3.82255 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
3.79878 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, CA12, CA2, CA7, DRD1, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, KCNH2, MET, PIK3CA, PIK3CB |
3.79015 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.76895 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, MIF, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SRC |
3.76069 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, MIF, PDE5A, PIK3CB, PTPN1, SRC |
3.75037 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MET, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.72941 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.70127 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.68476 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
3.68317 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.68317 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
3.66571 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, HMGCR, MIF, PTGS1, PTGS2 |
3.66188 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.63583 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
3.54728 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.53247 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.49954 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.48973 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.48973 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
3.43488 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.3928 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.39093 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, DRD1, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
3.39093 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, DRD1, HMGCR, PTGS2, SLC6A4, SRC |
3.39093 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, DRD1, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
3.37962 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, DRD1, GRM1, GRM3, GRM5, GRM8 |
3.37962 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.37125 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.37125 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.37125 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.37125 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TYR, XDH |
3.36619 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, FLT3, GRM1, GRM5, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
3.34863 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, NQO2, XDH |
3.2944 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, CYP3A4, HMGCR, TYR |
3.2944 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.28579 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.27903 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
3.22768 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.22579 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.22507 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.21411 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, CDC25B, CSNK2A1, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.20758 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, XDH |
3.19138 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9, PTGS2, TERT |
3.19138 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, HMGCR, IGF1R, MIF, PDE5A, PIK3CB, PTPN1, SRC |
3.19138 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.17909 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, PTGS2, SLC6A4 |
3.17909 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, CA2, CA7, DRD1, GRM5, KCNH2, MAOB, MIF, MMP9, PTGS2, SLC6A4 |
3.1754 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, FLT3, GRM1, HMGCR, IGF1R, KDR, MIF, PDE5A, PIK3CB, PTPN1, SRC, XDH |
3.1754 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3, HMGCR |
3.17279 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
3.17279 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, GRM5, MIF, PTPN1, SRC |
3.15371 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TYR, XDH |
3.14845 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
3.13837 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2C19, CYP2D6, CYP3A4, MAOB |
3.13837 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, DRD1, HCAR2, KCNH2, MIF, MMP12, PTGS2, SLC6A4, SRC, TERT |
3.13551 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, F3, GRM1, HCAR2, HMGCR, KCNH2, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PTGS2, SLC1A1, SLC6A4, SRC, TERT, XDH |
3.12955 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.11819 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.11771 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.05846 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, AURKB, CSNK2A1, CYP2D6, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
3.05207 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, HMGCR |
3.04762 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, MAOB |
3.03138 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.02248 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, DRD1, GRM1, GRM3, GRM5, GRM8 |
3.02161 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, AXL, CA2, CYP1B1, ESRRB, F3, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIM1, PTGS2, SLC1A1, SRC, TERT |
3.01418 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, MAOB, PDE5A, PIK3CB, SRC, XDH |
3.0099 |
[BP] GO:0019371 |
None
|
AKR1C3, PTGS1, PTGS2 |
3.00365 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
2.99956 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.97744 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, DRD1, HMGCR, PTGS2, SLC6A4 |
2.96686 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, DRD1, HMGCR, PTGS2, SLC6A4 |
2.96686 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, GRM1, HMGCR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT, TYR |
2.96332 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, MIF, PDE5A, PIK3CB, PTPN1, SRC |
2.92297 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
2.91481 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2, TERT |
2.90003 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.90003 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
2.90003 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.90003 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGS1, PTGS2 |
2.86241 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.86101 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.85611 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, ESR1, F3, FABP4, HMGCR, KDR, MET, MIF, MMP12, PPARA, PTGS2 |
2.85237 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.85237 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.85237 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.85237 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.85237 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.85237 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, DRD1, HMGCR, PTGS2, SLC6A4 |
2.84709 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, PPARA, SLC1A1, SLC6A2, SLC6A4 |
2.84681 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, AURKB, CDC25B, ESR1, ESR2, F3, FLT3, GRM1, GRM5, MET, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH |
2.83349 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, DRD1, HMGCR, PTGS2, SLC6A4 |
2.83349 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82158 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
2.82158 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
2.82158 |
[BP] GO:0097756 |
None
|
ADORA1, HMGCR, PTGS2, SLC6A4 |
2.80715 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KCNH2, KDR, PTGS2, SRC |
2.79332 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, ESR1, F3, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.7932 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CYP19A1, GRIK5, HCAR2, HMGCR, MAOB, MIF, MMP12, SLC6A4, SRC |
2.78788 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, DRD1, ESR1, FLT3, GRM5, IGF1R, MMP2, PTGS2, SLC6A4, SRC |
2.78321 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, DRD1, HMGCR, PTGS2, SLC6A4, SRC |
2.78042 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, MIF, PIK3CB |
2.76948 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.76948 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, CDC25B, DRD1, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.76691 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.739 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, KCNH2, MAOB, MMP9, PTGS2 |
2.71874 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, CYP19A1, DRD1, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.71302 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
2.71302 |
[BP] GO:0007268 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.70547 |
[BP] GO:0098916 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.70547 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.70266 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.68302 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, GRM5, PTPN1 |
2.66466 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.65726 |
[BP] GO:0099536 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.64127 |
[BP] GO:0099537 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.64127 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.61692 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57601 |
[BP] GO:0032225 |
None
|
DRD1, PTGS2, SLC6A4 |
2.57601 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
2.57601 |
[BP] GO:0042391 |
None
|
ADORA1, DRD1, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC |
2.5664 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, CYP1B1, DRD1, GRM1, GRM5, GRM8, HMGCR, KCNH2, PDE5A, PIK3CA, PTGS2, SLC6A4, SRC, TYR |
2.55856 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, HCAR2, PIK3CB, PTGS2 |
2.54461 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
2.54461 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CYP19A1, GRIK5, HCAR2, HMGCR, MAOB, MIF, MMP12, SLC6A4, SRC |
2.51748 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A4 |
2.50545 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, AURKB, CSNK2A1, CYP2D6, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.50545 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
MIF, MMP9, PTGS2, PTPN1, SRC |
2.49964 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, FLT3, GRM5, MIF, PTPN1, SRC |
2.4944 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, MAOB, PDE5A, XDH |
2.49321 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ESR1, HMGCR, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.47059 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, ESRRB, GRM3, GRM8, PDE5A, PPARA |
2.47059 |
[BP] GO:0007154 |
None
|
ADORA1, AKR1C3, AXL, DRD1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC1A1, SLC6A2 |
2.47059 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.47059 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.47059 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.47059 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.47059 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.47059 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.47059 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.47013 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, AKR1C3, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.46739 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, MAOB, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
2.46581 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, AURKB, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH |
2.46059 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.46026 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, ESRRB, GRM3, GRM8, PDE5A, PPARA |
2.40716 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SLC6A4, SRC, TYR |
2.40406 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.40381 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.3953 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, MET, MIF, PIK3CB, PIM1, SRC, TYR |
2.33876 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.31843 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
2.31843 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.31817 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
2.30535 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.29369 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.29365 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, MMP9, TERT |
2.28641 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.27803 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.27803 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, SRC |
2.25435 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.2417 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HMGCR, IGF1R, KCNH2, KDR, MET, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.23787 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.22459 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.22459 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.22459 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.22459 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22459 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.22459 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22459 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.22207 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, SRC |
2.20247 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.18177 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.16695 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SLC6A4, SRC, TYR |
2.13935 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, MET, PIK3CA |
2.13874 |
[BP] GO:0023052 |
None
|
ADORA1, DRD1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, KCNH2, SLC1A1, SLC6A2 |
2.13569 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.1348 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, CES1, CYP1B1, CYP3A4, HMGCR |
2.0984 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, PTGS2 |
2.09213 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, CYP1A1, HMGCR, PTGS2, SLC6A4, TYR |
2.08862 |
[BP] GO:0045932 |
None
|
ADORA1, PDE5A, PTGS2 |
2.08285 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.08013 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.07986 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07764 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.06679 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, PTGS2, SLC6A4 |
2.05144 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.04414 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.04414 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.04414 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, PPARA, RORC, SLC6A4, SRC |
2.04309 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.04309 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.04309 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.04309 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, KCNH2, PDE5A, PTGS2, SLC1A1 |
2.03975 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, HCAR2, MIF, MMP12, SLC6A4, SRC |
2.0375 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HMGCR, IGF1R, KCNH2, KDR, MET, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.02438 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.00143 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, CA9, DRD1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
4.23264 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, F10, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A4, SRC, TYR |
3.99686 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, F10, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TYR |
3.97525 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, F10, FLT3, GRIA2, HMGCR, HSD11B1, HSD17B2, PTGS1, PTGS2, PTPN1 |
3.92445 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, ESR1, F10, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A4, SRC, TERT |
3.82255 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CA4, DRD1, F10, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A4 |
3.75078 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, AXL, CA2, CA4, CA9, DRD1, F10, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PTGS2, SLC1A1, SLC6A2, SLC6A4, SRC |
3.35325 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.22579 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, GRIA2, HMGCR, HSD11B1, HSD17B2, PTGS1, PTGS2 |
2.79806 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, CA1, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, HMGCR, HSD11B1, HSD17B1, HSD17B2, KCNH2, KDR, MAOB, MIF, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC6A4, SRC, TERT, TYR, XDH |
2.56904 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A4 |
2.4944 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.33085 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC6A2, SLC6A4, SRC |
2.25435 |
[CC] GO:0005783 |
None
|
ADORA1, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, GRIK5, HMGCR, KDR, PTGS2, PTPN1, XDH |
2.18177 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4, SRC |
2.14857 |
[CC] GO:0014069 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.04414 |
[CC] GO:0099572 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.04414 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.02438 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
12.9116 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, F10, F3, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
9.86443 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.5866 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, MAOB, NQO2, PTGS1, PTGS2, TYR, XDH |
9.5866 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
9.23375 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.87933 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, TYR |
7.57894 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, HMGCR, HSD17B1, MAOB, NQO2, PTGS1, PTGS2, SRC, XDH |
7.20089 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
7.17902 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC |
7.14459 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, TYR |
6.98156 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC |
6.88958 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.70854 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4 |
6.55817 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.44088 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, XDH |
6.37339 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TYR, XDH |
6.36973 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
6.29279 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
6.05442 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.05151 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC |
5.94437 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HMGCR, HSD11B1, HSD17B1, HSD17B2, XDH |
5.86212 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
5.58066 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.45231 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.25136 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.97762 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.97762 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.88741 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.55748 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4, DRD1, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SLC6A4, SRC |
4.37482 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19, CYP2D6, CYP3A4 |
4.3555 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, NQO2, XDH |
4.30351 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, CSNK2A1, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MIF, MMP9, NQO2, PTGS2, SLC6A4, TERT, TYR, XDH |
4.21639 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
4.04564 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.85079 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
3.52765 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
3.52765 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, PPARA, RORC |
3.38999 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD17B1, HSD17B2 |
3.31408 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.22579 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.22579 |
[MF] GO:0030594 |
None
|
DRD1, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
3.21766 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD17B1, HSD17B2 |
3.21411 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
3.02367 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.00998 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.00365 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.85237 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.85237 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85237 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.82566 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, FLT3, HMGCR, KCNH2, MAOB, NQO2, PTGS2, SLC6A4, TERT, TYR, XDH |
2.81138 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
2.81138 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.47059 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.47059 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.47059 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.47059 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.47059 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.3949 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.3949 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, SRC |
2.34338 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.33085 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.29369 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.22459 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22459 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.22459 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.22459 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.22459 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.22459 |
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, KCNH2 |
2.07764 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, FLT3, HMGCR, KCNH2, MAOB, NQO2, PTGS2, SLC6A4, TERT, TYR, XDH |
2.0484 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.04414 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.04414 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.04309 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04309 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.00226 |